Preview Mode Links will not work in preview mode

Jun 21, 2023

Featuring perspectives from Dr Lyudmila A Bazhenova, Ms Kelly EH Goodwin, Dr Virginia Kaklamani, Ms Caroline Kuhlman, Ms Alexis N McKinney and Dr Zev Wainberg, including the following topics:

  • Introduction (0:00)
  • HER2 as a Therapeutic Target; Antibody-Drug Conjugates (6:15)
  • HER2-Positive Breast Cancer (23:08)
  • HER2-Positive Gastrointestinal Cancers (46:14)
  • HER2-Positive Non-Small Cell Lung Cancer (1:08:14)
  • Toxicities of Trastuzumab Deruxtecan (1:20:59)

NCPD information and select publications